Загрузка...
A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
OBJECTIVE: A pilot open label, single dose trial of fenobam, an mGluR5 antagonist, was conducted to provide an initial evaluation of safety and pharmacokinetics in adult males and females with fragile X syndrome (FXS). METHODS: Twelve subjects, recruited from two fragile X clinics, received a single...
Сохранить в:
| Главные авторы: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2658751/ https://ncbi.nlm.nih.gov/pubmed/19126569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmg.2008.063701 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|